Boston Scientific accounts are for healthcare professionals only.
Advancing science for more personalized neurological care
Explore our solutions in Deep Brain Stimulation (DBS), Spinal Cord Stimulation (SCS), and vertebrogenic pain relief designed to help you treat patients with movement disorder and chronic pain.
1524774118
Therapies and procedures
Featured
Deep brain stimulation (DBS) system
The Vercise Genus™ Deep Brain Stimulation (DBS) System offers the most therapy options* available and features the first and only FDA-approved 16-contact Vercise™ Cartesia™ X and Cartesia™ HX Directional Leads. When combined with Image Guided Programming using Illumina 3D™ technology, clinicians can quickly personalize therapy in each patient’s unique anatomy for optimal outcomes.
Resources
Reimbursement tools for physicians and administrators
Get assistance with procedure coding, pre-authorization, benefit verification, and claims denials.
MRI conditionality
Boston Scientific devices with ImageReady™ MRI Conditionality allow patients to safely undergo MRI scans.
Connect with our team
Find contact information, technical support, ordering and product information, and other resources.
Frequently asked questions
Illumina 3D technology, exclusively from Boston Scientific, is the latest FDA-approved advancement in Image Guided Programming. Ilumina 3D technology leverages intelligent algorithms to provide precise therapy with proven clinical outcomes.7 The Vercise Genus DBS System features the Vercise Cartesia X and Cartesia HX Directional Leads, allowing more flexibility in programming for personalized therapy. These leads offer the best in span, spacing and directionality, allowing precise targeting of neural structures.8
References
*Information for competitive devices excerpted from the literature published by Medtronic (M982261A015 Rev A, M939241A051 Rev A, M013074C001 Rev B, M982097A013 Rev A, M13075C001 Rev B, M019192C002 Rev A) and Abbott (ARTEN600150429 - B, ARTEN600102238 - A, ARTEN600266398 -A, ARTEN600308953 -A, ARTEN600308947 -A), and Schüpbach, Michael & Chabardes, Stephan & Matthies, Cordula & Pollo, Claudio & Steigerwald, Frank & Timmermann, Lars & Vandewalle, Veerle & Volkmann, Jens & Schuurman, P.. (2017). Directional leads for deep brain stimulation: Opportunities and challenges. Movement Disorders. 32. 10.1002/mds.27096. Steffen, J. K., Reker, P., Mennicken, F. K., Dembek, T. A., Dafsari, H. S., Fink, G. R., Visser-Vandewalle, V., & Barbe, M. T. (2020). Bipolar Directional Deep Brain Stimulation in Essential and Parkinsonian Tremor. Neuromodulation: Technology at the Neural Interface, 23(4), 543–549. DOI: 10.1111/ner.13109 Reker, P., Dembek, T. A., Becker, J., Visser-Vandewalle, V., & Timmermann, L. (2016). Directional deep brain stimulation: A case of avoiding dysarthria with bipolar directional current steering. Parkinsonism & Related Disorders, 31, 156-158. https://doi.org/10.1016/j.parkreldis.2016.08.007 Kirsch, A. D., Hassin-Baer, S., Matthies, C., Volkmann, J., & Steigerwald, F. (2018). Anodic versus cathodic neurostimulation of the subthalamic nucleus: A randomized-controlled study of acute clinical effects. Parkinsonism & Related Disorders, 55, 61-67. https://doi.org/10.1016/j.parkreldis.2018.05.015. Boston Scientific (Vercise ™ Neural Navigator 5 Software Programming Manual MP92736308-01)
- Gage E., et al. Rapid Onset of Analgesia during Trial Period Utilizing Fast-Acting Sub-Perception Therapy SCS [Abstract] NANS 2023 Annual Meeting, Jan 12-15, 2023. (n=44)
- Anitescu M., et al. Utilizing SCS Designed to Engage Surround Inhibition Using Fast-Acting Sub-Perception Therapy (FAST): Prospective, Multicenter, Long-Term Outcomes [Abstract] NANS 2025 Annual Meeting, Jan 30-Feb 1, 2025. (n=20)
- Metzger C., et al. Two-year Outcomes Using Fast-Acting Sub-perception Therapy for Spinal Cord Stimulation: Results of a Real-World Multicenter Study in the United States. Expert Rev Med Devices. Published online January 2025. (n=50)
- Bayerl S, Paz-Solis J, Matis G, et al. Two-year outcomes using fast-acting, sub-perception therapy for spinal cord stimulation: a European, real-world, multicenter experience. JCM. 2024;13(22):6999. (n=52)
- Ferro R. et al. Streamlining Spinal Cord Stimulation Therapy via Personalized Automation of Programming [Abstract] NANS 2025 Annual Meeting, Jan 30-Feb 1, 2025. (n=23)
- Fischgrund J, Rhyne A, Macadaeg K, et al. Long-term outcomes following intraosseous basivertebral nerve ablation for the treatment of chronic low back pain: 5-year treatment arm results from a prospective randomized double-blind sham-controlled multi-center study. Eur Spine J. 2020;29(8):1925-34. http://doi.org/10.1007/s00586-020-06448-x
- Mahsa Malekmohammadi et al 2022 J. Neural Eng. 19 046014 DOI 10.1088/1741-2552/ac7e6c
- Best is defined as the directional lead with the longest directional span and most directional levels Boston Scientific. (2024). Vercise™ Deep Brain Stimulation Systems Surgical Implant Manual. Medtronic. (2021). Medtronic Sensight™ Directional Lead Kit. https://www.medtronic.com/content/dam/emanuals/neuro/M982097A_a_013_view.pdf Abbott. (2021). Lead and Extensions Kits for Deep Brain Stimulation Systems. Clinician’s Manual. https://manuals.eifu.abbott/en/detail-screen.html